🔗 Share this article

Treasury head Rachel Reeves has revealed she is planning "specific steps to tackle household expense pressures" in the forthcoming Budget.

In comments to the BBC, she noted that reducing inflation is a shared duty of both the government and the Bank of England.

The United Kingdom's inflation rate is forecast to be the most elevated among the Group of Seven industrialized countries this calendar year and next.

Potential Energy Bill Measures

Reports indicate the administration could take action to lower utility costs, for example by reducing the current 5% level of VAT applied on energy.

A further approach is to reduce some of the government charges currently included in household expenses.

Budgetary Constraints and Expert Predictions

The government will receive the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for these measures.

The consensus from the majority of experts is that Reeves will have to declare tax rises or expenditure reductions in order to meet her self-imposed fiscal targets.

Previously on Thursday, calculations suggested there was a £22 billion shortfall for the chancellor to address, which is at the more modest range of forecasts.

"It is a collective responsibility between the central bank and the administration to continue tackling some of the causes of price increases," the Chancellor told reporters in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Revenue Pledges and Global Concerns

While a great deal of the attention has been on probable tax increases, the Treasury chief said the latest figures from the fiscal watchdog had not altered her pledge to campaign commitments not to increase rates on income tax, VAT or social security contributions.

She attributed an "uncertain world" with increasing international and trade tensions for the Budget tax moves, likely to be targeted on those "most able to pay."

International Trade Tensions

Referring to concerns about the United Kingdom's commercial links with China she said: "The UK's national security always are paramount."

Recent announcement by China to increase trade restrictions on rare earths and other materials that are key for high-technology production led American leader Donald Trump to threaten an additional 100% import tax on imports from China, raising the risk of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary called China's decision "commercial pressure" and "a global supply chain power grab."

Inquired about considering the American proposal to participate in its conflict with China, the Chancellor said she was "extremely troubled" by China's actions and urged the Chinese government "to avoid restrictions and restrict access."

She said the action was "harmful for the international commerce and generates additional challenges."

"It is my opinion there are areas where we must confront Chinese policies, but there are also significant chances to export to China's economy, including financial services and other areas of the economy. We've got to maintain that equilibrium appropriate."

The Treasury chief also confirmed she was working with other major economies "on our own essential resources approach, so that we are less reliant."

Health Service Medicine Costs and Investment

Reeves also admitted that the price the NHS spends on medicines could increase as a result of ongoing discussions with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

A number of the biggest global drug companies have said in recent statements that they are either delaying or scrapping operations in the United Kingdom, with several blaming the low prices they are receiving.

Last month, the Science Minister said the price the health service pays for drugs would must go up to halt businesses and pharmaceutical investment departing from the United Kingdom.

Reeves stated to media: "We have seen as a result of the cost structure, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the extent that they are in other European countries."

"Our aim is to make sure that patients getting treatment from the NHS are able to obtain the top life-saving treatments in the world. And so we are looking at these issues, and... aiming to attract increased capital into Britain."